Moxian, Inc. (OTCQB: MOXC) is a multi-national company that is committed to building a comprehensive solution using promotional platforms and social marketing to help businesses grow through social media. MOXC’s products enable other merchants to target their marketing, advertising campaigns, and promotional tools to their audiences by using data put together through the Moxian database. Moxian, Inc. now has two products: Moxian+ User App and Moxian+ Business App.

Moxian+ Business App offers merchants the toolkits to convert customers into members. This toolkit is made up of intelligent data analytics, a range of business tools, loyalty programs, and advertising opportunities. On the other hand, the Moxian+ User App allows consumers to search for merchants nearby to get recent news about events or promotions, and it includes an instant messenger feature, an online mall where the user can use virtual currencies to shop, a reward system, and, last but not least, a gaming platform that enables consumers to play for prizes.

The gamification that Moxian, Inc. uses in its Moxian+ User App allows users to choose from a range of exciting games to play. With this, consumers play and have the opportunity to win exciting gifts from MOXC’s merchants. This gaming model doesn’t just drive consumers to Moxian, but also to the merchants. This, in turn, allows the merchants involved to advertise, run marketing campaigns and learn more about their consumers through the platform. However, the question is: why use gamification in the Moxian+ User App? The answer is simple! Moxian is an evolutionary company that is using techniques to motivate and keep consumers excited.

Gamification has been used over the past few years as a way to motivate employees, create healthy competition among teams, generate a social vibe and much more. Gamification with consumers is also used for many reasons. These include: encouraging consumer loyalty, keeping customers engaged and adding a social and competitive stance to an app. According to the University of Pennsylvania, some of the key features to adding a level of gamification to an app or program include deciding on a goal, developing a loop, creating a sense of progression and adding levels. Moxian, Inc.’s Moxian+ User App does just this. The app offers exciting games on the platform that consumers can play and then win points to spend in a virtual mall that is provided by Moxian merchants. This system creates a win-win situation for consumers and merchants. It also adds another level to the tools that Moxian, Inc. uses to boost its business results.

For more information, visit the company’s website at www.Moxian.com

Let us hear your thoughts: Moxian, Inc. Message Board

International Stem Cell Corp. (OTCQB: ISCO) is a biotechnology company that works with parthenogenesis to treat diseases of the eyes, the nervous system, the liver, and more. Currently, ISCO is preparing for a phase I clinical trial of its proprietary human parthenogenetic stem cells-derived neural stem cells (ISC-hpNSC®) for the treatment of Parkinson’s disease (PD), a disease of the nervous system that affects mainly middle-aged and elderly people. The disease is marked by tremors, muscular rigidity, and slow movements. The company’s lead product, ISC-hpNSC, works in a different way than other conventional treatments. The stem cells enable protection of the remaining, fully-functional neurons of Parkinson’s disease patients. The testing ISCO has done on mice, rats, and non-human primates has backed its theory that a one-time transplant of ISC-hpNSC could alleviate current PD symptoms and prevent the disease from spreading.

Recently, Edison, an international equity research firm, initiated coverage on International Stem Cell Corp. The report focuses on ISCO’s parthenogenetic stem cell technology and how this technology has the potential to treat a variety of diseases. The report also includes an investment summary, a description of ISCO as a company, an outline of Parkinson’s disease, insight into ISCO’s cosmeceutical and biomedical business lines, a valuation, and a financial overview.

With the help of Cryoport, the world’s premier cryogenic logistics firm, International Stem Cell Corp. is rapidly approaching the start of its phase I clinical trial for the treatment of Parkinson’s disease. So far, there have been a number of cell therapy and gene therapy treatments that have been evaluated to find the cause of Parkinson’s. The studies ISCO has undertaken on non-human subjects have shown significant results.

According to the initial coverage issued by Edison: “ISCO presented results of its PD preclinical studies in October 2015 at Neuroscience 2015 in Chicago. The preclinical studies on 18 non-human primates showed that at 12 months, the transplanted cells had integrated into the dopamine fibers and dopamine levels post-mortem were significantly higher in the transplanted group versus the control group.”

As part of its impending clinical study, each patient will receive a scan at the beginning of the trial and at the six-month and 12-month lines after the procedure. Although these procedures do come with risks, they will be performed at the well-known Royal Melbourne Hospital in Australia and, if successful, could lead to larger phase II trials in 2017/2018.

For more information, visit www.internationalstemcell.com

Let us hear your thoughts: International Stem Cell Corp. Message Board

Earlier today, eXp World Holdings, Inc. (OTCQB: EXPI) announced that Glenn Sanford, the company’s founder and chief executive officer, has been invited to present at Mendix World, a two-day conference focused on strategic technology trends, digital transformation and insight into integrating technology with business. Mendix, the titular sponsor of the event, is a cloud-based, platform as a service firm which, through agile project management processes, helps organizations transform ideas into owned applications at a much faster rate than is possible using traditional programming platforms and methods.

Sanford is scheduled to participate in a panel discussion titled ‘Disrupting Traditional Markets through Technology’. This topic is particularly relevant to the EXPI founder, as eXp World Holdings, Inc., along with its subsidiaries, has successfully leveraged technological innovations to capture a foothold in a number of markets within the services industries. Most notably, EXPI launched eXp Realty, the Agent-Owned Cloud Brokerage™, which welcomed its 1,000th real estate professional into its family of agent-owners in the first quarter of this year.

“We’re looking forward to attending Mendix world and participating in the panel discussion,” Sanford stated in today’s news release. “Mendix allows businesses to innovate faster and, as a company, we have succeeded in disproving the notion that physical office space is an indispensable element of a successful real estate brokerage model or a necessary ingredient to building a community of professionals in a collaborative setting. In that sense, we have been disruptive in favor of our agents and brokers and we look forward to sharing our experience and insight with Mendix World attendees.”

This year’s conference will begin on June 7 in Rotterdam, the second-largest city in the Netherlands. To learn more, visit http://dtn.fm/96dF1

In recent weeks, EXPI has remained steadfast in its efforts to revolutionize the residential real estate brokerage industry. Last month, the company successfully launched eXp Realty in four new states and the District of Columbia, appointed a CEO and president of its real estate division and reported record financial results from the first quarter of 2016. Leveraging a network of more than 1,200 real estate professionals across 38 states and Alberta, Canada, EXPI achieved a year-over-year increase of 107 percent in quarterly revenues for the quarter ended March 31, reporting over $7.1 million.

Through a partnership with VirBELA, LLC, a leading developer of immersive online worlds, EXPI maintains exclusive rights to its avatar-based platform in the real estate industry, as well as an option to exclusive rights within a number of vertical industries. As the company continues to expand its network of agent-owners across North America, this agreement strategically positions EXPI to maintain its leadership position in the digital real estate brokerage space while continuing to attract some of the industry’s best and brightest to its Agent-Owned Cloud Brokerage.

For more information, visit the company’s website at http://investors.exprealty.com

Let us hear your thoughts: eXp World Holdings, Inc. Message Board

If a picture is worth a thousand words, what’s the value of a three-minute video like the Irish Experience Tour you’ll find on Monaker Group Inc.’s (OTCQB: MKGI) NextTrip website? Quite a lot, say the analysts at Globe Small Cap Research, who, in a summary of their research findings, write ‘Monaker’s core strength is its proprietary video-centered technology’. Globe Small Cap has found that Monaker ‘is expanding its video-centric capabilities at an important time in the development of the Internet. Video is booming across the Internet and having significant impacts on marketers and advertisers that rely on the Internet to communicate brand and product messages.’

Indeed it is. The video clips and still pictures that appear on Monaker Group’s websites are the hors d’oeuvres of anticipation before the pièce de résistance of the vacation itself. In this digital age, no story can be properly told without motion pictures. The marketing message transmitted by video is more engaging and requires less effort from the recipient. We’ve known this since the era of Charlie Chaplin and the Keystone Cops. That is why many people have become acquainted with the great classics of literature, such as Tolstoy’s War and Peace or Tolkien’s Lord of the Rings, only through their film portrayals.

The Globe Small Cap report discusses how clever marketers like Monaker have responded to the increasing sophistication of the internet, noting that there has been a convergence of the purely informational announcement and advertising copy into what is known today as content marketing. The report explains that ‘content marketing is the approach of combining an advertisement for goods or services with internet content that is of interest to the would-be purchaser. A content marketing approach allows advertisers to target clearly defined audiences in order to drive actions of prospective customers. Marketers that use the “hook” of the content in order to draw the user in and then interject an advertisement and a call to action in order to elicit a purchasing response. This is done so effectively, that the lines between advertising and content have been forever blurred.’

Content marketing is a shift of emphasis within an advertisement. Ads have always played the important role of providing information to the public about products and services. Now, in content marketing, more weight is given to selling the product. The next stage in the evolution of the advertising to content marketing progression is the addition of video. In its earliest days, video use was mainly for entertainment. Now, there’s a realization that, like pictures and verbal forms, it is simply another medium of communication.

Video is captivating. The Globe Small Cap report, citing eMarketing, states that ‘during mid-2015, online video overtook social media relative to the amount of time spent per day online’. Research by HighQ confirms this: ‘…approximately 55% of Americans watch online videos every day with the average American adult spending one hour and 16 minutes each day watching video on digital devices. Growth relative to this area has been staggering as consumers spent only 21 minutes per day watching online videos in 2011.’

Monaker’s portfolio of assets and alliances form a somewhat ‘vertical’ complimentary structure. Through Maupintour, holidaymakers can visit popular haunts or travel the back roads. Maupintour is the longest established high-end travel company in the United States. In October 2015, the company acquired AlwaysOnVacation, an online alternative lodging marketplace. Alternative lodging is accommodation, such as home rentals, that can act as a substitute for rooms in hotels. AlwaysOnVacation, founded in 2006, came with its 65,000 properties in 120 countries and over six million monthly visitors. In April 2016, Monaker entered into a partnership with Recruiter.com, an online global recruiting and career service, which will make Monaker’s customized travel and lifestyle offerings available to the recruiting agency’s ‘three million current members and followers’.

NextTrip is the next stage in Monaker’s safari to place convenience at vacationers’ fingertips. Launched in February 2016, this booking engine integrates all of the company’s acquired technologies with very select channel partners. This makes NextTrip the first booking solution to include conventional lodging, alternative lodging, and unused timeshare and resort inventory all in one place. The technology allows consumers to search and book from the timeshare inventory in real-time without any timeshare solicitations.

For more information, visit www.monakergroup.com

Let us hear your thoughts: Monaker Group, Inc. Message Board

The financial tech, or “fintech,” phenomenon is changing the landscape of financial services. Traditional ways of providing financial services such as making payments, accepting deposits, and lending and risk management are being abandoned as new channels, made possible by digital technology, are opened up.

Technological innovation hasn’t just given rise to a new type of institution, the fintech, but has affected the culture of establishment institutions. In a conversation (http://dtn.fm/egT2M) with Michael Bloomberg, founder and majority owner of Bloomberg LP, Goldman Sachs (NYSE: GS) chairman and CEO Lloyd Blankfein acknowledged that, “Goldman Sachs is a technology firm.” The same sentiment was expressed in JPMorgan Chase’s latest Annual Report, in which the bank’s COO, Matt Zames, proclaims, “We are a technology company.”

So too is Alternet Systems, Inc. (OTC: ALYI), a company whose mission is to provide innovative solutions that facilitate and expedite commerce by enhancing customer experience and improving efficiency.

To do so, Alternet has transformed itself into an accelerator of high growth, emerging companies in the multi-channel payments, point-of-sale and data analytics fields. In April 2015, the company signed an agreement with R4 Technologies, LLC to market and promote R4’s purpose-built cloud platform for micro-segment data, insight and engagement to help brands leverage data and automate yield optimization. Alternet will collaborate with R4 across Latin America and the Caribbean. In May 2015, Alternet signed a commercial distribution software reseller agreement with Brazil-based APPI Tecnologia S/A. As a leading IT company, APPI specializes in the integration and development of technical solutions and software for the electronic transaction payment industry. Alternet will promote APPI’s unique, innovative, and efficient solutions in the United States, Canada and the Caribbean.

Alternet intends to deliver technology solutions to financial organizations that manage a wide range of payment channels, including development engines that extend the capabilities of processing across all capture devices. These include point-of-sale (POS), mobile phones, tablets, PCs and web-based applications. These solutions deliver channel specific abilities. Alternet will collaborate with leading manufacturers to deliver solutions that meet the needs of device and channel management. Growing demand from mobile point-of-sale terminals, along with increased emphasis on advanced analytics features, are significant factors for the growing demand for software in the point-of-sale terminals market.

Leading Alternet into the future is company chairman and CEO Henryk Dabrowski. Dabrowski has more than 25 years of experience creating, leading and successfully harvesting information technology and telecom ventures on a global basis. Over the last 10 years he has actively invested in both public and privately held companies. He has extensive experience in emerging financial transactions platforms, including mobile wallets, convergent payments schemes, network file systems (NFS), stored value and prepaid services. From October 2009 to March 2014, Dabrowski was chairman and CEO of Utiba Americas, a leading developer of mobile financial services software solutions, which through his efforts reached 66% market share in the Americas. Under his leadership, Utiba Americas successfully engaged projects with America Movil, Digicel Group, Tigo, Citibank and several other banks and Mobile Network Operators. Utiba Americas was successfully and profitably sold to Amdocs (NASDAQ: DOX) in March of 2014.

Before that, Dabrowski was CEO of a joint venture with the Chinese firm Tianjin Contactless Payment Systems (TCPS), which provided multiple NFS prepaid fare collections systems for the transportation industry in the Americas.

From February 2002 to December 2010, Dabrowski was chairman and CEO of TekVoice Communications, an international Voice over IP services and wholesale billing platform provider. During his tenure at TekVoice, Dabrowski built a highly successful network of international services, customers and partnerships in Brazil, Bolivia, Venezuela, Colombia, Peru, El Salvador, Mexico, Honduras, Argentina and Haiti. And prior to that, Dabrowski held executive positions at RKM IT Solutions, a Latin American IT & telephony integrations solution provider, and Vox2Vox Communications, a global IP telephony and value added services provider.

For more information, visit www.alternetsystems.com

Let us hear your thoughts: Alternet Systems, Inc. Message Board

Before the opening bell, International Stem Cell Corp. (OTCQB: ISCO) announced the publication of results from a 12-month preclinical, non-human primate study. The data highlights the safety and efficacy of ISCO’s proprietary human parthenogenetic stem cells-derived neural stem cells (ISC-hpNSC®) for the treatment of Parkinson’s disease. According to the results of this study, transplantation of the neural cells was both safe and well tolerated by non-human primates, with the animals demonstrating no serious adverse events throughout the 12-month trial.

“The publication of the data in the peer-reviewed and highly-respected journal, Cell Transplantation, brings to conclusion the preclinical stage of ISCO’s Parkinson’s disease program,” Russell Kern, Ph.D., chief scientific officer of ISCO, stated in this morning’s news release. “The data provides further evidence that parthenogenetic neural stem cells can be effective in treating the symptoms of Parkinson’s disease and, along with the previously [submitted] safety data, formed the basis of our application to the Australian regulatory authorities to move this program into the clinic.”

To view the full article and abstract, visit http://dtn.fm/kB2eZ

Review of data stemming from this preclinical study played a key role in ISCO’s authorization from the Therapeutics Goods Administration of Australia to initiate a phase I/IIa clinical trial of its innovative ISC-hpNSC for the treatment of moderate to severe Parkinson’s disease. In December, the company announced this approval and entered into a master clinical research agreement with the Florey Institute of Neuroscience and Mental Health, one of the world’s leading brain research centers, to conduct the impending dose escalation trial. In March, ISCO commenced enrollment for its phase I trial. Preliminary clinical data stemming from this study is expected in the fourth quarter of this year.

According to the Parkinson’s Disease Foundation, an estimated seven to 10 million people worldwide are currently living with Parkinson’s disease, making it the second most common neurodegenerative disease. Currently without a cure, the combined direct and indirect costs stemming from this debilitating condition, including treatment, social security payments and lost income from inability to work, are estimated at $25 billion per year in the United States alone.

In preclinical studies, ISCO’s ISC-hpNSC have shown effective in improving Parkinson’s disease symptoms by increasing the presence of dopaminergic neurons and bolstering dopamine concentration in the brain through neurotrophic support and dopaminergic neuron replacement. In particular, the cells’ ability to replace and protect dopaminergic neurons while restoring neural function is expected to offer significant potential benefit to patients suffering from moderate to severe Parkinson’s disease.

For more information, visit www.internationalstemcell.com

Let us hear your thoughts: International Stem Cell Corp. Message Board

Rennova Health, Inc. (NASDAQ: RNVA), Florida-based provider of technologies and services to the healthcare industry, has successfully faced a number of industry-wide challenges in recent years due to the steadfast focus on strict compliance by its executive team and the resulting potential that approach offers toward expanding provider contracts. It’s an accomplishment based upon a blend of industry knowledge and a sound approach to management and finance.

• Thomas Mika (Chairman) – With an MBA from Harvard and an undergraduate degree in Microbiology, Mr. Mika has held a number of executive positions in the healthcare and other technology industries, and has an extensive background in building healthcare and software companies. He is Chairman, President, and Acting CFO of healthcare data analytics company CollabRx, which merged with Rennova in November 2015. Earlier he was President and Chief Executive Officer of Tegal Corporation, becoming Chairman of the Board the following year. At Tegal he had served as Executive Vice President, Chief Financial Officer, and was on the Board of Directors, managing the activities that led to the company’s IPO in 1995.
• Seamus Lagan (President, Chief Executive Officer, Director) – Mr. Lagan’s expertise includes over two decades in the restructuring, development, and management of both public and private companies. His guidance has been critical to the growth of Rennova Health, as well as to the company’s achieving an impressive NASDAQ listing. Mr. Lagan was initially approached to help in the development of new business opportunities for the company, and his efforts have supported the structuring of the company’s business plan as well as the securing of vital funding. Mr. Lagan has also served as the CEO of two principal subsidiaries of Medytox Solutions.
• Jason Adams (Chief Financial Officer) – Mr. Adams has held senior financial executive positions with Alico and Source Interlink Companies, and was the Chief Financial Officer of West Central Behavioral Health, a provider of mental health services to communities in New Hampshire.
• Sri Bharat Madireddy, PhD (COO of Medytox Diagnostics, CEO of Rennova owned Laboratories) – Dr. Madireddy serves Rennova as Technical Supervisor and Director LC-MSMS for Toxicology operations. He is Board Certified in Clinical Chemistry by the American Association of Bioanalysts, and has extensive experience in analytical chemistry and toxicology.

For more information, visit www.RennovaHealth.com

Yesterday, the 5th Annual SeeThruEquity Conference took place at Convene in New York City, connecting more than 30 presenting companies with microcap-focused investors, sponsors and industry professionals. The conference featured 30-minute presentations from each of the presenting companies, as well as opportunities for prospective investors to meet one-on-one with the companies’ management teams. In total, SeeThruEquity has hosted 20 investor conferences, attracting more than 4,400 investors and arranging over 1,800 one-on-one meetings.

SeeThruEquity’s quarterly investor conferences deliver considerable value to presenting companies, including an opportunity to speak to a high quality audience of institutional and sophisticated high-net worth investors. The independent research firm also initiates complimentary research coverage on all presenting companies, giving investors a more detailed look at the companies’ positions in their respective markets.

Presenting companies at yesterday’s conference included:

3TL Technologies Corp. (OTCQB: TTMZF), Advanced Medical Isotope Corp. (OTC: ADMD), Amarantus Bioscience Holdings, Inc. (OTCQX: AMBS), Apivio Systems, Inc. (OTC: APVVF), Avant Diagnostics, Inc. (OTCQB: AVDX), BIO-key International, Inc. (OTCQB: BKYI), Blue Sphere Corp. (OTCQB: BLSP), Calmare Therapeutics Inc. (OTCQB: CTTC), Cellectar Biosciences, Inc. (NASDAQ: CLRB), Chineseinvestors.com, Inc. (OTCQB: CIIX), COPsync, Inc. (NASDAQ: COYN), DelMar Pharmaceuticals, Inc. (OTCQX: DMPI), Endonovo Therapeutics, Inc. (OTCQB: ENDV), General Employment Enterprises, Inc. (NYSE MKT: JOB), HealthWarehouse.com, Inc. (OTCQB: HEWA), HydroPhi Technologies Group, Inc. (OTC: HPTG), IEG Holdings Corp. (OTCQX: IEGH), International Western Petroleum, Inc. (OTCQB: INWP), NanoViricides, Inc. (NYSE MKT: NNVC), O2Micro International Ltd. (NASDAQ: OIIM), PAR Technology Corp. (NYSE: PAR), PCM, Inc. (NASDAQ: PCMI), Pivot Pharmaceuticals, Inc. (OTCQB: PVOTF), Predictive Technology Group, Inc. (OTC: PRED), Pressure BioSciences, Inc. (OTCQB: PBIO), Progressive Care, Inc. (OTC: RXMD), Rhino Resource Partners LP (OTCQB: RHNO), RiceBran Technologies (NASDAQ: RIBT), Staffing 360 Solutions, Inc. (NASDAQ: STAF), TapImmune, Inc. (OTCQB: TPIV), Yangtze River Development Ltd. (OTC: YERR)

The conference also included a panel on Regulation A+, the newly-revamped regulation that allows private companies to raise up to $50 million through unaccredited investor equity crowdfunding as an alternative to venture capital firms or other institutional capital providers. The panel was moderated by Brian Balbirnie and Michael Colon of Issuer Direct Corporation (NYSE MKT: ISDR), parent company of global news distribution service Accesswire.

For more information, visit www.seethruequity.com

Giggles N’ Hugs (OTCQB: GIGL) is the company behind three award-winning family restaurants based in Los Angeles. The company’s restaurants feature a one-of-a-kind concept in which adults can relax and children can act exactly their age. GIGL offers a range of activities for children at affordable prices, including parties, and is open seven days a week. It uses a variety of children’s entertainers and has won a number of awards. In addition, the company has regular promotions and a membership program with perks, special kids events, and a lot more. It’s unique, healthy menu and upscale atmosphere has attracted a celebrity clientele.

The company has a market cap of $4.03 million with an attractive investors plan. Some of the highlights Giggles N’ Hugs offers to investors include a niche demographic, multiple revenue drivers, increasing financial performance, and mall operator cooperation. GIGL continues to gather interest from a number of external sources in different countries that want to expand the concept in the Unites States and globally, which is one of the many reasons why Giggles N’ Hugs is attending June’s LD Micro Conference Main Event, where it will be presenting.

Founded in 2006, LD Micro is an independent resource in the microcap space. Over the past 10 years, it has grown from a small newsletter to an event with over 200 companies attending. The opportunity to attend is great for companies looking for investors, as the event attracts brokers, bankers, and visitors looking to make an investment.

Aside from attending the event, GIGL will be presenting on June 9, 2016. This means GIGL will be in the spotlight in front of over 1,000 investors. In addition to this, GIGL will be providing one-on-one meetings with its management team throughout the entire day.

In a recent news release, Joey Parsi, CEO of Giggles N’ Hugs, had this to say: “We’re excited to present at the LD Micro Conference main event. With our Century City location just a few minutes away from the conference site, this is a great opportunity for us to meet with bankers, brokers, analysts and investors right here in our backyard.”

Learn more by visiting www.gigglesnhugs.com

Let us hear your thoughts: Giggles ‘N Hugs, Inc. Message Board

For months, Content Checked Holdings, Inc. (OTCQB: CNCK) has been securing coverage in high-profile media outlets in an effort to get the word out about its family of dietary apps. The increasingly-recognizable brand has already garnered attention from Forbes, USA Today, ABC, CBS, NBC, Fox, Los Angeles Business Journal, Yahoo, and a number of other widely-viewed publications. In early May, Content Checked built on this progress when Tory Tedrow, CNSC, a registered dietician and member of the CNCK team, authored an article titled ‘Should You Try a Plant-Based Diet?’ for WhoSay, a celebrity-powered media firm with well over half a million social media followers.

In the article, Tedrow offers a few compelling reasons to consider switching to a plant-based diet. Unlike a vegetarian or vegan diet, she explains in the article, all foods are allowed on a plant-based diet, but the majority of foods should come from plant sources, such as fruits, vegetables, whole grains, nuts, and beans. Tedrow highlights potential cost-savings, health benefits and an inherent safeguard against overeating as primary advantages of these nutrient-dense, filling diets.

To view the full article, visit http://dtn.fm/UG19d

In addition to providing dietary tips, Tedrow’s WhoSay article also provides valuable exposure to Content Checked and its family of health apps.

Content Checked has also found success in securing partnerships with related apps and companies in order to increase its brand awareness. Last month, the company announced a cross-promotional partnership with ATLETO, a new social sports app that connects everyday athletes. Through this partnership, ATLETO will support Content Checked via promotional posts across its social media channels, further elevating the company’s brand within the athletic community. Content Checked entered into a similar partnership in April with Leaner Creamer, the only all-natural powdered coffee creamer that promotes weight loss and appetite suppression.

To view the company’s full financials, visit the following link: http://dtn.fm/sIJ7M

For more information, visit www.contentchecked.com

Let us hear your thoughts: ContentChecked Holdings Inc. Message Board